40 results match your criteria: "University of Jean-Monnet[Affiliation]"
Semin Oncol Nurs
October 2020
Prehabilitation, Activity, Cancer, Exercise, Survivorship (PACES) Research Group, University of Canberra, Canberra, Australia; Discipline of Sport and Exercise Science, Faculty of Health, University of Canberra, Canberra, Australia.
Background: The purpose of this systematic review and meta-analysis was to evaluate the safety (adverse events), feasibility (recruitment, retention, and adherence) and effectiveness of exercise among individuals with lung cancer.
Data Sources: Electronic databases (CINAHL, Cochrane, Ebscohost, MEDLINE, Pubmed, ProQuest Health and Medical Complete, ProQuest Nursing and Allied Health Source, Science Direct, and SPORTDiscus) were searched for randomized, controlled, exercise trials involving individuals with lung cancer that were published prior to May 1, 2020. The PEDro scale was used to assess risk of bias, and the Common Terminology Criteria for Adverse Events was used to classify adverse event severity.
J Infect Dis
March 2021
Department of Infectious and Tropical Diseases, University Hospital of Saint-Etienne, Saint-Etienne, France.
Background: Identifying people with HIV (PWH) at risk for chronic kidney disease, cardiovascular events, and death is crucial. We evaluated biomarkers to predict all-cause mortality and cardiovascular events, and measured glomerular filtration rate (mGFR) slope.
Methods: Biomarkers were measured at enrollment.
J Am Geriatr Soc
October 2020
Groupe Immunité des Muqueuses et Agents Pathogènes-EA3064, University Hospital of Saint-Etienne, Saint-Etienne, France.
JMIR Aging
May 2020
Autonomic Nervous System Research Laboratory, University of Jean Monnet, Saint-Etienne, France.
Front Psychiatry
July 2018
Department of Psychiatry, University Hospital of Saint-Etienne, Saint-Etienne, France.
Patients with schizophrenia exhibit impaired social cognition, especially in the recognition and expression of facial emotions, aspects of communication profoundly interlinked in an embodied approach of cognition. Nevertheless, many training programs have been developed that focus on either of these deficits but not both. We therefore designed a training program, , intended to remedy the 2 deficits and investigated its feasibility and effects in patients with schizophrenia.
View Article and Find Full Text PDFEur Urol Focus
April 2018
Department of Urology, North Hospital, CHU Saint-Etienne, University of Jean-Monnet, Saint-Etienne, France; Inserm U1059, Saint-Etienne, France. Electronic address:
Background: Circulating microRNAs (miRNAs) in exosomes are emerging as clinically useful tools for cancer detection. However, little is known about their diagnostic impact in clear-cell renal cell carcinoma (ccRCC).
Objective: To investigate whether miRNAs in serum exosomes can serve as biomarkers in ccRCC.
Clin Neurophysiol
September 2017
Dycog Lab, Lyon Neuroscience Research Center - Inserm U 1028/CNRS UMR 5292, University of Lyon, France; Epilepsy and Functional Neurology Department, Neurological Hospital Pierre Wertheimer, Hospices Civils de Lyon, Bron, France.
Objective: Due to limited information from scalp electroencephalographic (EEG) recordings, brain areas driving changes in cardiac rhythm during Temporal lobe (TL) seizures are not clearly identified. Using stereotactic EEG (SEEG) recordings, we aimed at identifying which of the brain regions involved in autonomic control trigger ictal tachycardia.
Methods: The neural activity of several mesial temporal lobe structures including amygdala, hippocampus, insula, and lateral temporal lobe recorded with SEEG were collected during 37 TL seizures in 9 patients, using indices based on High Frequency Activity (HFA).
Urol Oncol
May 2017
Department of Urology, North Hospital, CHU of Saint-Etienne, University of Jean-Monnet, Saint-Etienne, France.
Background: Recent findings show that cell-free miRNAs are stable in biological fluid. Urine provides an alternative to blood serum or plasma as a potential source of tumor biomarkers. MiR-210 is proven to be overexpressed in patients with a clear cell renal cell carcinoma (ccRCC).
View Article and Find Full Text PDFPsychiatry Res
July 2016
Department of Psychiatry, University Hospital of Saint-Etienne, Saint-Etienne, France; EA TAPE, University of Jean Monnet, Saint-Étienne, France.
Many data suggest a disjunction between decreased emotional expressions and relatively preserved experience of and ability to assess emotions in schizophrenia. Based in an embodied approach of cognition, several studies have highlighted affective stimulus-response congruency effect in healthy subjects that show a direct link between the perception of emotion and associated motor responses. This study investigated whether the categorization of emotional words involves an automatic sensorimotor simulation of approach and avoidance behaviors.
View Article and Find Full Text PDFEur Urol
May 2016
Department of Urology, North Hospital, CHU de Saint-Etienne, University of Jean-Monnet, Saint-Etienne, France. Electronic address:
Context: The relative benefits and harms of hormonal treatment (HT) versus no or deferred HT in patients with nonmetastatic prostate cancer (PCa) relapse after primary curative therapy are controversial.
Objective: To assess the effectiveness of HT for nonmetastatic PCa relapse, prognostic factors for treatment outcome, timing of treatment, and the most effective treatment strategy to provide guidance for clinical practice.
Evidence Acquisition: A systematic literature search was undertaken incorporating Medline, Embase, and the Cochrane Library (search ended March 2015).
Int J Cancer
June 2015
Department of Urology, North Hospital, CHU of Saint-Etienne, University of Jean-Monnet, Saint-Etienne, France; Zhejiang Cancer Research Institute, Zhejiang Province Cancer Hospital, Hangzhou, China.
There is limited research on cell-free RNA (cf-RNA) in the urine of cancer patients. The present study was performed to detect the cf-RNA in the urine of patients with clear cell renal cell carcinoma (ccRCC). Ninety-five urine samples from ccRCC patients and 50 urine samples from control subjects were analyzed.
View Article and Find Full Text PDFUrol Oncol
November 2014
Department of Urology, North Hospital, CHU de Saint-Etienne, University of Jean-Monnet, Saint-Etienne, France; LINA, EA 4624, Faculty of Medicine, University of Jean-Monnet, Saint-Etienne, France.
Introduction: A disintegrin and metalloproteinase-17 (ADAM17) plays an important role in biological activity in different cancers. Its expression and prognostic value have not been studied in clear cell renal cell carcinoma (cRCC). The objective of this study was to explore the prognostic value of ADAM17 in patients with cRCC.
View Article and Find Full Text PDFHistol Histopathol
September 2013
Department of Urology, North Hospital, CHU Saint-Etienne, University of Jean-Monnet, Saint-Etienne, France.
Introduction: The expression of CXCR4 is implicated in the metastatic dissemination of different cancers. The information on its prognostic value has been very limited in clear cell renal cell carcinoma (ccRCC). Our objective was to explore the prognostic value of CXCR4 in ccRCC.
View Article and Find Full Text PDFExp Mol Pathol
February 2013
Clinical Immunology Laboratory, North Hospital, CHU of Saint-Etienne, University of Jean-Monnet, Saint-Etienne, France.
Objective: Our objective was to evaluate the levels of miR-210 in tumor and serum samples of conventional renal cell cancer (cRCC) patients to explore whether circulating miR-210 in serum can be used as a biomarker for the detection of cRCC.
Methods: The paired samples from primary cRCC tumors and adjacent non-tumoral renal parenchyma were collected from 32 patients with cRCC. Serum samples were obtained from 68 patients with a cRCC before surgery, 10 samples after one week of surgery, and 42 healthy individuals were included in this study.
Conf Proc IEEE Eng Med Biol Soc
October 2012
Laboratory of Graphic Informatics and Vision Engineering, University of Jean Monnet, 42000, St-Etienne, France
This paper introduces a new visual device concept for patients with partially sight loss named Visual Signal Adaptive Restitution (ViSAR). This new concept adapt the signal visual itself to the patient's visual discomfort in real time. While most device tends to compensate for physiology anomaly, ViSAR concept allows to improve the patient-signal interaction and to favor an active vision.
View Article and Find Full Text PDF